[The treatment of carcinoid of the small intestine with octreotide and alpha-interferon. A call for participation in a randomized study].
Ahrén
B
B
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002276:Carcinoid Tumor / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007391:International Cooperation; D007414:Intestinal Neoplasms / Q000188:drug therapy*; D007421:Intestine, Small; D015282:Octreotide / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D013548:Sweden
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D016898:Interferon-alpha; D015282:Octreotide
Behandlung des Dünndarmkarzinoids mit Octreotid und alpha-Interferon. Aufruf zur Teilnahme an einer randomisierten Studie.